Cargando…

PTEN potentiation of oncolytic HSV therapy for glioblastoma

Detalles Bibliográficos
Autores principales:	Migliarese, Christian, Wakimoto, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258231/ https://www.ncbi.nlm.nih.gov/pubmed/37313454 http://dx.doi.org/10.1016/j.omto.2023.05.005

Ejemplares similares

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
por: Ning, Jianfang, et al.
Publicado: (2014)

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
por: Saha, Dipongkor, et al.
Publicado: (2017)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
por: Appolloni, Irene, et al.
Publicado: (2021)

Oncolytic HSV: Underpinnings of Tumor Susceptibility
por: Kangas, Chase, et al.
Publicado: (2021)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy
por: Sahu, Upasana, et al.
Publicado: (2023)

Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas
por: Monie, Dileep D., et al.
Publicado: (2021)

Editorial: Recent advances in oncolytic virus therapy for brain tumors
por: Askari, Fatemeh Sana, et al.
Publicado: (2023)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV
por: Jahan, Nusrat, et al.
Publicado: (2021)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
por: Li, Ming, et al.
Publicado: (2020)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
por: Aldrak, Norah, et al.
Publicado: (2021)

Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
por: Tang, Tianyu, et al.
Publicado: (2022)

Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
por: Kawamura, Yoichiro, et al.
Publicado: (2022)

Harnessing PTEN’s Growth Potential in Neuronal Development and Disease
por: Fuchs, Joachim, et al.
Publicado: (2020)

Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
por: Howard, Faith, et al.
Publicado: (2022)

The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles
por: Tang, Guijin, et al.
Publicado: (2023)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
por: Robilotti, Elizabeth, et al.
Publicado: (2023)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)

STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells
por: Okemoto, Kazuo, et al.
Publicado: (2013)

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
por: Menotti, Laura, et al.
Publicado: (2018)

Immunovirotherapy for glioblastoma
por: Ning, Jianfang, et al.
Publicado: (2014)

Two roads for oncolytic immunotherapy development
por: Kaufman, Howard L., et al.
Publicado: (2019)

Glioblastoma: State of the Art and Future Perspectives
por: Tabatabai, Ghazaleh, et al.
Publicado: (2019)

Modulating the tumor microenvironment via oncolytic virus and PI3K inhibition synergistically restores immune checkpoint therapy response in PTEN-deficient glioblastoma
por: Xing, Fan, et al.
Publicado: (2021)

Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles
por: Fu, Xinping, et al.
Publicado: (2018)

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
por: Simpson, G R, et al.
Publicado: (2012)

Oncolytic virotherapy targeting the IL15 pathway
por: Yoo, So Young, et al.
Publicado: (2023)

Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
por: Godlewski, Jakub, et al.
Publicado: (2021)

Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1
por: Hoang, Huy-Dung, et al.
Publicado: (2023)

Enhancing The Bystander Killing Effect Of An Oncolytic HSV By Arming It With A Secretable Apoptosis Activator
por: Loya, Shana Marie Williamson, et al.
Publicado: (2015)

HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
por: Koch, Marilin S., et al.
Publicado: (2020)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Oncolytic Virus-Induced Autophagy in Glioblastoma
por: Kamynina, Margarita, et al.
Publicado: (2021)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
por: Russell, Luke, et al.
Publicado: (2018)

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
por: Kennedy, Edward M., et al.
Publicado: (2020)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2021)

Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
por: Hamad, Azzam, et al.
Publicado: (2023)

What goes in the regulatory clinical pharmacology package for an oncolytic virus?
por: Yum, Sun Young, et al.
Publicado: (2023)

Oncolytic virotherapy meets the human organoid technology for pancreatic cancers
por: Fiorini, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_88m19naoo61g00l1h8fhfoi0qt